PHIO PHARMACEUTICALS CORP. — Cash Flow Charts
52 quarters of history · ending 2024-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+25.7% +$697K
$-2M
Free Cash Flow
$-1K
Investing Cash Flow
$8K
Financing Cash Flow↓-43.6% -$1M
$1M
Capex
$1K
Acquisitions
$-100K
Stock-Based Comp↑+433.3% +$39K
$48K
Debt Issued
$0
D&A↓-100.0% -$10K
$0
SBC Allocated Expense↑+433.3% +$39K
$48K